Welcome to our dedicated page for Accolade news (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade stock.
Accolade, Inc. (ACCD) delivers technology-powered healthcare solutions that combine virtual care with expert clinical navigation. This news hub provides investors and industry professionals with essential updates on the company’s strategic initiatives and market position.
Track official press releases, earnings announcements, and operational developments through our curated collection. Find timely information on healthcare partnerships, service expansions, and technology innovations that shape Accolade’s role in personalized care solutions.
Our repository includes updates across key business areas: financial results, leadership changes, clinical program enhancements, and regulatory milestones. Each entry is sourced directly from company communications to ensure accuracy and compliance.
Bookmark this page for streamlined access to ACCD’s evolving story in healthcare technology. Monitor how the company’s unique blend of digital tools and clinical expertise continues to redefine employer-sponsored and individual healthcare navigation.
Accolade, Inc. (NASDAQ: ACCD) has announced its upcoming Analyst Day event scheduled for May 8, 2023, at the Wynn Las Vegas. The event will start at 1pm PT and will be available via a live webcast for pre-registered attendees. During the event, Accolade’s management will share insights into the company’s long-term vision, along with details on its product, clinical, ecosystem, and financial strategies. Interested participants can register through ir.accolade.com. A replay of the event will also be accessible after the live session.
Accolade focuses on providing personalized healthcare solutions to millions, ensuring high consumer satisfaction ratings exceeding 90%. For more information, visit accolade.com.
Accolade, Inc. (NASDAQ: ACCD) announced that it will release its fiscal fourth quarter 2023 financial results on April 27, 2023, after market close. A conference call will follow at 4:30 p.m. E.T. to discuss the results.
The call will be accessible via telephone or internet, with pre-registration required for the phone option. A replay will be available shortly after the call concludes. Accolade specializes in personalized healthcare solutions, enhancing healthcare experiences for millions through virtual primary care, mental health services, and care navigation.
The company consistently achieves over 90% consumer satisfaction ratings, reflecting its commitment to improving healthcare delivery.
Accolade, Inc. (Nasdaq: ACCD) has partnered with Lyra Health to enhance behavioral health care access for employers. This collaboration, part of Accolade's Trusted Partner Ecosystem, aims to address the barriers faced by U.S. workers in accessing mental health services. A recent Gallup survey revealed over half of workers lack awareness of available resources. Lyra Health provides evidence-based services, aiming for prompt access with an average wait time of only two days for appointments. The partnership promises improved mental health support for joint customers without additional costs.
Accolade, Inc. (NASDAQ: ACCD) announces a significant change in its Board of Directors as Co-founder Michael Hilton transitions from his role as Chief Product Officer to joining the Board, succeeding Tom Neff. Hilton has been pivotal in reshaping Accolade's market strategy since 2015, enhancing its position from a service provider to a product leader. CEO Rajeev Singh commended Hilton's experience, while expressing gratitude for Neff's long-standing contributions. The company's approach combines advanced healthcare services with intelligent technology to improve patient experiences, consistently achieving over 90% consumer satisfaction ratings.
FAQ
What is the current stock price of Accolade (ACCD)?
What is the market cap of Accolade (ACCD)?
